GH21

· Suzhou Genhouse Bio Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for GH21, covering 2024-07-08 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors [Phase 1, Phase 2]

See pricing